← Back to Search

SMART@Home Digital Platform for Asthma Management

N/A
Recruiting
Led By Kevin Hommel, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 11-17
Patients diagnosed with a chronic medical condition requiring regular treatment, i.e., asthma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to create a digital platform to provide remote care of medically complex patients with better clinical validity and patient engagement.

Who is the study for?
This trial is for young people aged 11-17 with asthma who need regular treatment. They and their caregivers must speak English fluently. It's not open to those with developmental disorders or serious mental illnesses like schizophrenia, as noted in medical records.
What is being tested?
The SMART@Home feasibility trial is testing a digital platform designed to help manage complex patient care remotely. It includes an app that connects to Bluetooth devices for tracking asthma and integrates with the Epic health record system.
What are the potential side effects?
Since this trial involves a digital platform rather than medication, traditional side effects are not applicable. However, there may be issues related to usability or technical problems with the app or connected devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 11 and 17 years old.
Select...
I have a chronic condition like asthma that needs regular treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Medication Adherence
Number of days app used

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SMART@HomeExperimental Treatment1 Intervention
Use of the SMART@Home app for medication and symptom tracking, spirometry feedback
Group II: ControlActive Control1 Intervention
Usual Care

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
839 Previous Clinical Trials
6,565,578 Total Patients Enrolled
16 Trials studying Asthma
2,597 Patients Enrolled for Asthma
Matt Wortman, PhDStudy ChairChildren's Hospital Medical Center, Cincinnati
Kevin Hommel, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
1 Previous Clinical Trials
160 Total Patients Enrolled
Rachelle Ramsey, PhDStudy ChairChildren's Hospital Medical Center, Cincinnati
~0 spots leftby Dec 2024